|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2001-9-24
|
|
pubmed:abstractText |
Boron neutron-capture therapy (BNCT) is a drug-targeted binary radiotherapy for cancer. The (10)B capture of thermal neutrons induces secondary radiation within cells during irradiation. The most widely used boron carrier is 4-dihydroxyborylphenylalanine (BPA). The duration and timing of the irradiation is adjusted by monitoring (10)B concentrations in whole blood.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0009-9147
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1796-803
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11568089-Adult,
pubmed-meshheading:11568089-Aged,
pubmed-meshheading:11568089-Boron,
pubmed-meshheading:11568089-Boron Compounds,
pubmed-meshheading:11568089-Boron Neutron Capture Therapy,
pubmed-meshheading:11568089-Female,
pubmed-meshheading:11568089-Hematocrit,
pubmed-meshheading:11568089-Humans,
pubmed-meshheading:11568089-Indicators and Reagents,
pubmed-meshheading:11568089-Male,
pubmed-meshheading:11568089-Mass Spectrometry,
pubmed-meshheading:11568089-Middle Aged,
pubmed-meshheading:11568089-Phenylalanine,
pubmed-meshheading:11568089-Sensitivity and Specificity,
pubmed-meshheading:11568089-Spectrophotometry, Atomic
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Atomic emission method for total boron in blood during neutron-capture therapy.
|
|
pubmed:affiliation |
HUCH Clinical Research Institute, Ltd., PO Box 105, FIN-00029 HUCH Helsinki, Finland. juha.laakso@helsinki.fi
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, Non-U.S. Gov't
|
